Thursday, July 8, 2010

Methylglyoxal in Manuka Honey – Correlation with Antibacterial Properties

Abstract

A perfect linear correlation was found for methylglyoxal levels in 61 samples of Manuka honey, ranging from 189 to 835 mg/kg, and the corresponding antibacterial activities of the samples, which were between 12.4% and 30.9% equivalent phenol concentration. This clearly underlines that methylglyoxal is the dominant bioactive compound in Manuka honey and above concentrations of around 150 mg/kg directly responsible for the characteristic antibacterial properties of Manuka honey. Methylglyoxal can be a suitable tool for labeling the unique bioactivity of Manuka honey.

Introduction

Manuka honey, derived from the Manuka tree (Leptospermum scoparium) in New Zealand, is well-known for a pronounced antibacterial activity which cannot be found in any other honey. Manuka honey has been reported to exhibit antimicrobial activity against pathogenic bacteria such as Staphylococcus aureus and Helicobacter pylori, making this honey to a promising functional food for the treatment of wounds, stomach ulcers, etc. Besides hydrogen peroxide, which is produced in most conventional honeys by the endogenous enzyme glucoseoxidase, several other non-peroxide factors were discussed to be responsible for the unique antibacterial activity of Manuka honey.

The Unique Manuka Factor (UMF) was introduced years ago, leading to a classification of premium products based on microbiological assays. A UMF of 10, for instance, has the same antibacterial activity to a 10% solution of phenol. Recently, researchers were able to demonstrate that the surprisingly high amounts of the 1,2-dicarbonyl compound methylglyoxal are present in Manuka honey. Methylglyoxal, at the levels at which were found it in Manuka honey, proved to be another non-peroxide antibacterial constituent. This observation was confirmed by scientists. The purpose of the present study was to investigate to which extent methylglyoxal is responsible for the non-peroxide antibacterial activity of Manuka honey, in order to check whether it is possible to back-reference from the methylglyoxal content to the antibacterial properties of a honey sample.

Materials and Methods

The source of the 61 samples of Manuka honey from New Zealand came from drums of honey selected on a spread of non-peroxide contents and of varying ages. The amount of methylglyoxal was measured as the corresponding quinoxaline after pre-column derivatisation with o-phenylendiamine using RP-HPLC with UV detection. The data for non-peroxide antibacterial activity were analyzed by a specially appointed laboratory for testing for antibacterial activity using criteria laid down by the Honey Research Unit at Waikato University, New Zealand. Antibacterial activity was expressed as equivalent phenol concentration (% w/v). This value is used commercially as the Unique Manuka Factor (UMF).

Results and Discussion

Methylglyoxal levels in 61 samples of Manuka honey ranged from 189 to 835 mg/kg honey. Corresponding antibacterial activities were between 12.4 and 30.9% equivalent phenol concentration. A good linear correlation (y = 8.388 + 0.0263x; r2 = 0.905) between methylglyoxal and the antibacterial activity was found. This indicates that methylglyoxal is directly responsible for the characteristic antibacterial properties of Manuka honey. Our data is in perfect agreement with results published by Adams who had reported data for 49 samples of Manuka honey. In their study, concentrations of methylglyoxal as measured according to Mavric ranged from 25 to 709 mg/kg.

Corresponding antibacterial activity was between “not detectable” and 27.5% equivalent phenol concentration. Among the samples analyzed by Adams, 30 samples had antibacterial activities higher or equal 10% equivalent phenol concentration. Plotting these 30 samples together with data obtained in our study, a perfect match of the data sets can be obtained. This remarkable agreement of results obtained in two independent studies clearly underlines the final statement that methylglyoxal is the dominant bioactive compound in Manuka honey and starting from concentrations of approximately 150 mg/kg is exclusively responsible for the pronounced antibacterial activity. Due to limited sensitivity and inaccuracy of the used test system, data obtained for antibacterial activities below 10% equivalent phenol concentration must be handled with care. This may explain the fact that the corresponding regression lines in Figure 1 do not pass through the origin (parameter a = 8.388 or 7.783, respectively). Furthermore, for such low antibacterial activities, other factors such as polyphenols, organic acids or currently unknown compounds may additionally contribute to non-peroxide antibacterial properties.

In conclusion, methylglyoxal is a unique antibacterial compound found in high concentrations in Manuka honeys from New Zealand and directly responsible for the specific antibacterial activity of these samples. Methylglyoxal can serve as a suitable tool for the labeling of the bioactivity of commercial products.



Figure 1. (A) correlation between methylglyoxal and antibacterial activity for 61 samples of Manuka honey analyzed in this study, (B) data analyzed in this study plus data from Allen shown as filled triangles

2 comments:

Anonymous said...
This comment has been removed by a blog administrator.
Anonymous said...
This comment has been removed by a blog administrator.